# 10FoldMed **Source:** https://www.startuphub.ai/startups/10foldmed **Profile type:** Startup > Israeli startup developing non-invasive technology to treat obesity by reversing insulin resistance. ## About 10FoldMed is an early-stage startup based in Israel with the vision to treat obesity and metabolic diseases. Their proprietary 10Fold™ technology aims to reverse insulin resistance through non-invasive destruction of visceral fat cells. ## Key facts - **Slug:** 10foldmed - **Website:** https://www.10foldmed.com/ - **Location:** Tel Aviv, Israel - **Founded:** 2020-07-01 - **Employees:** 7572 - **Operating status:** Active - **Sectors / tags:** Healthcare, Obesity, MedTech, HealthTech, Biotech, Longevity, Obesity Treatment, Metabolic Diseases, Medical Devices - **Social:** - LinkedIn: https://www.linkedin.com/company/wix-com - Twitter: https://twitter.com/Wix - Facebook: https://www.facebook.com/wix ## Frequently asked ### What does 10FoldMed do? 10FoldMed is an early-stage startup based in Israel with the vision to treat obesity and metabolic diseases. Their proprietary 10Fold™ technology aims to reverse insulin resistance through non-invasive destruction of visceral fat cells. ### What is 10FoldMed's revenue? StartupHub estimates 10FoldMed's annual revenue at $1.4B (range $1.3B to $3.3B, 65% confidence), based on comparable companies in the sector. ### Where is 10FoldMed headquartered? 10FoldMed is headquartered in Tel Aviv, Israel. ### When was 10FoldMed founded? 10FoldMed was founded in 2020. ### What industry does 10FoldMed operate in? 10FoldMed operates in Healthcare, Obesity, MedTech, HealthTech, Biotech, Longevity. ### How many employees does 10FoldMed have? 10FoldMed has approximately 7,572 people on record. ## JSON-LD Structured data aligned with this page's `